Europe
New insights into the architecture of the brain have been revealed by scientists at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and their collaborators.
Even when manufacturing facilities are producing, widespread illness causes other delays.
The companies intend to push the vaccine candidate into human trials by April of this year, subject to regulatory approval.
Consumer healthcare company HRA Pharma grew their total group revenues by 20.8% in 2019 with EBITDA growing by 30%
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
Although news of the COVID-19 pandemic has tended to dominate the news cycle, including for the biopharma industry, there were a number of clinical trial announcements last week. Here’s a look.
Hospitals and laboratories will be able to run the test on Roche’s fully automated cobas 6800 and cobas 8800 Systems, which are already in wide use in the U.S. and internationally.
Recipharm, a leading contract development and manufacturing organisation, is pleased to note the FDA’s approval of Perrigo’s AB-rated generic of ProAir HFA.
Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.
This new technique uses real-time, next-generation sequencing that uses tiny amounts of microbial cell-free DNA from sepsis patients’ plasma.
PRESS RELEASES